OrthoSpace completes financing — 5 key notes

Spinal Tech
Laura Dyrda -

OrthoSpace completed financing which will facilitate growth in the future.

Here are five things to know:

 

1. The financing was led by HealthpointCapital.

 

2. The financing also included existing investors Smith & Nephew and TriVentures.

 

3. The proceeds will facilitate continued market adoption, clinical study programs and entry into the emerging markets.

 

4. OrthoSpace's flagship product is InSpace, a disruptive technology for treating severe rotator cuff tears. The technology addresses a large growing market segment with limited treatment options for the continuum-of-care for rotator cuff injury.

 

5. The terms of the agreement were not disclosed.

 

"With five years of clinical experience and over 5,000 procedures completed, we have developed a loyal following among surgeons in Europe and Israel," said Assaf Dekel, MD, OrthoSpace's co-founder and medical director.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.